Rankings
▼
Calendar
PRTA Q4 2025 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21,000
-99.0% YoY
Gross Profit
-$921,000
-4385.7% margin
Operating Income
-$27M
-129576.2% margin
Net Income
-$22M
-102804.8% margin
EPS (Diluted)
$-0.40
QoQ Revenue Growth
-99.1%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$27M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$327M
Total Liabilities
$46M
Stockholders' Equity
$280M
Cash & Equivalents
$308M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21,000
$2M
-99.0%
Gross Profit
-$921,000
$2M
-143.4%
Operating Income
-$27M
-$65M
+58.1%
Net Income
-$22M
-$58M
+62.7%
Revenue Segments
Collaboration
$21,000
100%
← FY 2025
All Quarters